This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Mediterraneibacter gnavus: NCBI 33038, [species]

Back to details

| [Ruminococcus] gnavus| ATCC 29149| Ruminococcus gnavus| Ruminococcus gnavus Moore et al. 1976| VPI C7-9

  1. Fermentation and Short-Chain Fatty Acid Production:

    • Ruminococcus gnavus, like other bacteria in the gut, is involved in the fermentation of dietary fibers and complex carbohydrates. This fermentation process results in the production of short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate. SCFAs play various roles in gut health, including providing an energy source for colonocytes and influencing immune function.
  2. Metabolism of Complex Polysaccharides:

    • Ruminococcus gnavus possesses the enzymatic machinery necessary for the breakdown of complex polysaccharides. This metabolic capacity allows the bacterium to extract energy and nutrients from dietary sources that are otherwise indigestible by the host.
  3. Dietary Influence:

    • The abundance and activity of Ruminococcus gnavus, like other gut bacteria, can be influenced by dietary factors. Diets rich in fiber and plant-based foods provide substrates for the fermentation processes carried out by these bacteria.
  4. Associations with Health Conditions:

    • Changes in the abundance of Ruminococcus gnavus have been observed in studies of the gut microbiota in various health conditions. Alterations in the relative abundance of this species have been associated with conditions such as inflammatory bowel disease (IBD) and other gastrointestinal disorders. However, the specific roles of Ruminococcus gnavus in these conditions are still being investigated, and the relationship may be complex.
  5. Immunomodulation:

    • Ruminococcus gnavus, like other members of the gut microbiota, can interact with the host's immune system. These interactions are complex and can influence immune responses in the gut.
  6. Association with Mucin Degradation:

    • Some strains of Ruminococcus gnavus have been associated with the degradation of mucin, a glycoprotein that lines the gut epithelium. Mucin degradation can influence the integrity of the mucosal barrier and may be relevant in certain health conditions.

Other Sources for more information:

Legend

Mediterraneibacter gnavus impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.47576293349266050.6569302082061768Blautia argiParent Taxa
0.31702604889869690.6374447345733643Rothia amaraeParent Taxa
0.310468047857284550.5469252467155457[Clostridium] scindensParent Taxa
0.310425668954849240.5510187745094299Thomasclavelia ramosaParent Taxa
0.3035467863082886-0.5547027587890625Bradyrhizobium sp. BTAi1Parent Taxa
0.30140787363052370.5452139377593994Enterocloster bolteaeParent Taxa
0.27911236882209780.4961720407009125Blautia parvulaParent Taxa
0.262963354587554930.4867260456085205Anaerostipes caccaeParent Taxa
0.26025092601776123-0.3878878057003021Olivibacter sp. LS-1Parent Taxa
0.253916591405868530.4718417227268219Blautia hanseniiParent Taxa
0.253195792436599730.47532790899276733Blautia productaParent Taxa

Other bacteria of the same rank impacting Mediterraneibacter gnavus

R2SlopeTax NameParent Chart
0.53720510005950930.768512487411499Blautia argiParent Taxa
0.345613151788711550.6267045140266418Blautia hanseniiParent Taxa
0.34055128693580630.5958747267723083[Clostridium] scindensParent Taxa
0.33467024564743040.6195819973945618Blautia parvulaParent Taxa
0.328186362981796260.5801454186439514Thomasclavelia ramosaParent Taxa
0.323431998491287230.6011961102485657Blautia productaParent Taxa
0.31263631582260130.5635491013526917Enterocloster bolteaeParent Taxa
0.297030180692672730.5923770666122437Anaerostipes caccaeParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]